NVIDIA insider files Form 144 to sell 3,500 RSU shares (09/19/2025)
Rhea-AI Filing Summary
Notice of proposed sale: This Form 144 reports an intended sale of 3,500 shares of common stock of the issuer through Morgan Stanley Smith Barney LLC on or about 09/19/2025, with an aggregate market value of $616,840.00. The shares were acquired as restricted stock units and vested/paid on 09/17/2025. The filer previously sold 4,500 shares on 06/20/2025 under a listed 10b5-1 sales program, generating gross proceeds of $646,469.10. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
Positive
- Broker identified: Morgan Stanley Smith Barney LLC is designated to execute the sale, providing institutional execution.
- Transaction detail transparency: Filing specifies acquisition date (09/17/2025), nature (Restricted Stock Units), planned sale date (09/19/2025), and aggregate value ($616,840.00).
- Prior 10b5-1 sale disclosed: 4,500 shares sold on 06/20/2025 for $646,469.10, indicating prior planned trading activity was reported.
Negative
- None.
Insights
TL;DR: Small executive sale of recently vested RSUs; transaction size appears immaterial to large-cap issuer.
The filing documents a proposed sale of 3,500 common shares acquired as restricted stock units on 09/17/2025 and earmarked for sale through Morgan Stanley on 09/19/2025 at an aggregate value of $616,840. A prior 10b5-1 sale of 4,500 shares on 06/20/2025 produced $646,469.10. Taken together, these transactions are routine insider liquidity events and, based on the absolute sizes reported, are unlikely to be materially impactful to the issuer's market capitalization.
TL;DR: Notice follows procedural requirements; inclusion of 10b5-1 reference and seller representation suggests compliance focus.
The Form 144 captures requisite details: acquisition date (09/17/2025), nature (RSUs), broker identification, and planned sale date (09/19/2025). The filing also discloses a recent 10b5-1 sale (06/20/2025) and includes the standard attestation against undisclosed material adverse information. These elements indicate adherence to reporting and trading-plan disclosure protocols rather than any governance concern.